Thank you for your post.
The study that was in the news on 12th December looked at the preventive effects of anastrozole in women with a family history of breast cancer. The findings were encouraging, showing the drug continued to be effective for five years after it was stopped. The women taking part in this study were at a high risk of cancer and the drug was taken to reduce their risk of breast cancer.
The drug anastrozole is one of a group of drugs called aromatase inhibitors, which also includes letrozole and exemestane. All three drugs have similar effects in treating breast cancer and no drug is better than another. It is usual for your specialist to explain why you are taking one of this group of drugs. You could contact your medical team to discuss their choice of aromatase inhibitors. The aromatase inhibitors all work by reducing the amount of oestrogen made in the body and can be used in the treatment of breast cancer.
Do call our free, confidential Helpline if you would like to talk this through or have any further questions. The number is 0808 800 6000.
Our opening hours are Monday to Friday 9am - 4pm and 9am -1pm on Saturday. Out of hours you can leave a message and we will call you back when we next open.
Please be aware that we will close at 12.30pm on Tuesday 24 December, and be open again from 9am on Thursday 2 January 2020
Breast Cancer Now Nurse
This thread will now be closed from further replies. If you have any additional questions or would like to provide feedback, please start a new thread.
Thanks for posting your question.
We hope to be able to respond to you tomorrow.
In the meantime our Helpline is open from 9am tomorrow if you would like to talk things through.
If you do phone our Helpline please let us know that you have asked a question on our forum so that we know your query has been answered. Thank you
With best wishes.
Ask Our Nurses Co-ordinator
Please read the Ask Our Nurses disclaimer .
Hello nurses, I imagine it's not just me that's a bit confused about the study in the news on 12th December that anastrozole should be recommended to more women. My thoughts were that the study was aimed at women at risk of bc, not who've been diagnosed and that us folks on other aromatase inhibitors like letrozole needn't wonder about switching to anastrozole because they all do the same thing basically, it's just there weren't so many studies on anastrozole compared to letrozole? Also it seemed to me it was comparing not other AIs but anastrozole with tamoxifen which is prescribed to pre-menopausal women mostly and women need to be post-menopause for AIs. So basically if we're on an AI other than anastrozole it's ok to stay on it and the only reason to consider switching would be if we can't cope with the side effects and trying another type might help? Hope this makes sense! Thanks for being there for us all, it really makes a difference